164 related articles for article (PubMed ID: 23806066)
21. p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression.
Wu W; Silbajoris RA; Whang YE; Graves LM; Bromberg PA; Samet JM
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L883-9. PubMed ID: 15980035
[TBL] [Abstract][Full Text] [Related]
22. AKT facilitates EGFR trafficking and degradation by phosphorylating and activating PIKfyve.
Er EE; Mendoza MC; Mackey AM; Rameh LE; Blenis J
Sci Signal; 2013 Jun; 6(279):ra45. PubMed ID: 23757022
[TBL] [Abstract][Full Text] [Related]
23. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.
de Graeff P; Crijns AP; Ten Hoor KA; Klip HG; Hollema H; Oien K; Bartlett JM; Wisman GB; de Bock GH; de Vries EG; de Jong S; van der Zee AG
Br J Cancer; 2008 Jul; 99(2):341-9. PubMed ID: 18628764
[TBL] [Abstract][Full Text] [Related]
24. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells.
Lee CW; Lin CC; Lin WN; Liang KC; Luo SF; Wu CB; Wang SW; Yang CM
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L799-812. PubMed ID: 17158602
[TBL] [Abstract][Full Text] [Related]
25. Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece.
Sozopoulos E; Litsiou H; Voutsinas G; Mitsiades N; Anagnostakis N; Tseva T; Patsouris E; Tseleni-Balafouta S
Endocr Pathol; 2010 Jun; 21(2):90-100. PubMed ID: 20186503
[TBL] [Abstract][Full Text] [Related]
26. PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.
Esteva FJ; Guo H; Zhang S; Santa-Maria C; Stone S; Lanchbury JS; Sahin AA; Hortobagyi GN; Yu D
Am J Pathol; 2010 Oct; 177(4):1647-56. PubMed ID: 20813970
[TBL] [Abstract][Full Text] [Related]
27. Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.
He P; Shen N; Gao G; Jiang X; Sun H; Zhou D; Xu N; Nong L; Ren K
Cell Physiol Biochem; 2016; 39(4):1281-94. PubMed ID: 27606614
[TBL] [Abstract][Full Text] [Related]
28. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
29. Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.
Kimple RJ; Vaseva AV; Cox AD; Baerman KM; Calvo BF; Tepper JE; Shields JM; Sartor CI
Clin Cancer Res; 2010 Feb; 16(3):912-23. PubMed ID: 20103665
[TBL] [Abstract][Full Text] [Related]
30. HIF-1α promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT pathway.
Zhang HX; Yang JJ; Zhang SA; Zhang SM; Wang JX; Xu ZY; Lin RY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6077-6084. PubMed ID: 30280794
[TBL] [Abstract][Full Text] [Related]
31. Investigation of EGFR/pi3k/Akt signaling pathway in seminomas.
Guerra F; Quintana S; Giustina S; Mendeluk G; Jufe L; Avagnina MA; Díaz LB; Palaoro LA
Biotech Histochem; 2021 Feb; 96(2):125-137. PubMed ID: 32597316
[TBL] [Abstract][Full Text] [Related]
32. Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations.
Huang HN; Huang WC; Lin CH; Chiang YC; Huang HY; Kuo KT
Hum Pathol; 2014 Nov; 45(11):2318-25. PubMed ID: 25281027
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.
Bumrungthai S; Munjal K; Nandekar S; Cooper K; Ekalaksananan T; Pientong C; Evans MF
J Transl Med; 2015 Jul; 13():244. PubMed ID: 26209091
[TBL] [Abstract][Full Text] [Related]
34. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
Gupta AK; McKenna WG; Weber CN; Feldman MD; Goldsmith JD; Mick R; Machtay M; Rosenthal DI; Bakanauskas VJ; Cerniglia GJ; Bernhard EJ; Weber RS; Muschel RJ
Clin Cancer Res; 2002 Mar; 8(3):885-92. PubMed ID: 11895923
[TBL] [Abstract][Full Text] [Related]
35. EGFR signals to mTOR through PKC and independently of Akt in glioma.
Fan QW; Cheng C; Knight ZA; Haas-Kogan D; Stokoe D; James CD; McCormick F; Shokat KM; Weiss WA
Sci Signal; 2009 Jan; 2(55):ra4. PubMed ID: 19176518
[TBL] [Abstract][Full Text] [Related]
36. EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line.
Treda C; Popeda M; Ksiazkiewicz M; Grzela DP; Walczak MP; Banaszczyk M; Peciak J; Stoczynska-Fidelus E; Rieske P
PLoS One; 2016; 11(5):e0155230. PubMed ID: 27153109
[TBL] [Abstract][Full Text] [Related]
37. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.
Knobbe CB; Reifenberger G
Brain Pathol; 2003 Oct; 13(4):507-18. PubMed ID: 14655756
[TBL] [Abstract][Full Text] [Related]
38. Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
Shi J; Yao D; Liu W; Wang N; Lv H; Zhang G; Ji M; Xu L; He N; Shi B; Hou P
BMC Cancer; 2012 Feb; 12():50. PubMed ID: 22292935
[TBL] [Abstract][Full Text] [Related]
39. Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition.
Young NR; Liu J; Pierce C; Wei TF; Grushko T; Olopade OI; Liu W; Shen C; Seiwert TY; Cohen EE
Mol Oncol; 2013 Jun; 7(3):359-68. PubMed ID: 23200321
[TBL] [Abstract][Full Text] [Related]
40. Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.
Shultz JC; Goehe RW; Wijesinghe DS; Murudkar C; Hawkins AJ; Shay JW; Minna JD; Chalfant CE
Cancer Res; 2010 Nov; 70(22):9185-96. PubMed ID: 21045158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
